Comparison of drug survival between infliximab and adalimumab in inflammatory bowel disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of drug survival between infliximab and adalimumab in inflammatory bowel disease
Authors
Keywords
-
Journal
International Journal of Clinical Pharmacy
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-31
DOI
10.1007/s11096-020-00978-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Is the Pharmacokinetic Profile of a First Anti-TNF Predictive of the Clinical Outcome and Pharmacokinetics of a Second Anti-TNF?
- (2018) Xavier Roblin et al. INFLAMMATORY BOWEL DISEASES
- Therapeutic Drug Monitoring of Biologics for Inflammatory Bowel Disease: An Answer to Optimized Treatment?
- (2018) Hannah Hoseyni et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Treatment Persistence of Infliximab Versus Adalimumab in Ulcerative Colitis: A 16-Year Single-Center Experience
- (2018) Lieven Pouillon et al. INFLAMMATORY BOWEL DISEASES
- Infliximab Trough Levels at Induction to Predict Treatment Failure During Maintenance
- (2017) Claire Liefferinckx et al. INFLAMMATORY BOWEL DISEASES
- Treatment Persistence for Infliximab Versus Adalimumab in Crohnʼs Disease
- (2017) Pablo Olivera et al. INFLAMMATORY BOWEL DISEASES
- Factors Associated with Discontinuation of Anti-TNF Inhibitors Among Persons with IBD
- (2017) Laura E. Targownik et al. INFLAMMATORY BOWEL DISEASES
- Application of Population Pharmacokinetic Modeling for Individualized Infliximab Dosing Strategies in Crohn Disease
- (2017) Adam Frymoyer et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- A Retrospective Claims Database Study on Drug Utilization in Japanese Patients with Crohn’s Disease Treated with Adalimumab or Infliximab
- (2016) Kaoru Yokoyama et al. ADVANCES IN THERAPY
- Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease
- (2016) J. Cosnes et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study
- (2016) J. D. Doecke et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab
- (2016) B. Ungar et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases
- (2016) Bella Ungar et al. Clinical Gastroenterology and Hepatology
- Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis
- (2016) Franck Carbonnel et al. GASTROENTEROLOGY
- Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
- (2016) A. Menter et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Azathioprine and 6-Mercaptopurine: A Meta-analysis
- (2015) David S. Kotlyar et al. Clinical Gastroenterology and Hepatology
- Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment
- (2015) E. G. Quetglas et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Risk of Lymphoma in Patients With Ulcerative Colitis Treated With Thiopurines: A Nationwide Retrospective Cohort Study
- (2013) Nabeel Khan et al. GASTROENTEROLOGY
- Long-term Outcome of Patients With Crohn's Disease Who Respond to Azathioprine
- (2012) Marine Camus et al. Clinical Gastroenterology and Hepatology
- Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study
- (2012) Mirthe Emilie van der Valk et al. GUT
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2011) William J. Sandborn et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now